Computational Drug Discovery for Small-Molecule Teams
BEIT Inc. has raised $3.5M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in February 2026.
BEIT Inc.'s investors include DCVC, Kindred Capital, Creative Destruction Lab, European Innovation Council Fund, Bloomberg Beta.
BEIT Inc. is headquartered in Kraków, Poland.
Computational Drug Discovery for Small-Molecule Teams
BEIT Inc. is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"BEIT Inc. — Funding & Investors." VCBacked, February 4, 2026, https://www.vcbacked.co/company/beit-inc. Accessed September 29, 2026.
VCBacked. (2026). BEIT Inc. — Funding & Investors. Retrieved September 29, 2026, from https://www.vcbacked.co/company/beit-inc
{{cite web |title=BEIT Inc. — Funding & Investors |url=https://www.vcbacked.co/company/beit-inc |website=VCBacked |access-date=September 29, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated